InvestorsObserver
×
News Home

Is Liquidia Corp (LQDA) a Good Buy in the Biotechnology Industry?

Monday, August 21, 2023 10:17 AM | InvestorsObserver Analysts

Mentioned in this article

Is Liquidia Corp (LQDA) a Good Buy in the Biotechnology Industry?

The 72 rating InvestorsObserver gives to Liquidia Corp (LQDA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 93 percent of stocks in the Biotechnology industry, LQDA’s 72 overall rating means the stock scores better than 72 percent of all stocks.

Overall Score - 72
LQDA has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on LQDA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 72 means the stock is more attractive than 72 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Liquidia Corp Stock Today?

Liquidia Corp (LQDA) stock is lower by -1.44% while the S&P 500 has gained 0.44% as of 10:15 AM on Monday, Aug 21. LQDA is down -$0.10 from the previous closing price of $6.96 on volume of 230,286 shares. Over the past year the S&P 500 has risen 6.07% while LQDA is down -9.97%. LQDA lost -$0.79 per share the over the last 12 months. Click Here to get the full Stock Report for Liquidia Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App